Stifel Nicolaus Has Lowered Expectations for Trupanion (NASDAQ:TRUP) Stock Price

Key Points

• Stifel Nicolaus cut its price target on Trupanion from $35 to $31 and maintained a "hold" rating, while analyst consensus remains a "Hold" with an average target of $44.50.
• Shares traded at $25.49, near the 1‑year low of $24.32 and well below the 200‑day moving average of $35.59, with a P/E of 56.65 indicating a relatively rich valuation against current prices.
• Trupanion's latest quarter showed $0.13 EPS (missed by $0.01) and revenue growth of 11.7%, and insiders sold about 21,072 shares (~$569k) in the last quarter.

Trupanion (NASDAQ:TRUP - Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $35.00 to $31.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a "hold" rating on the financial services provider's stock. Stifel Nicolaus' price objective suggests a potential upside of 21.62% from the stock's previous close.

Other equities analysts have also recently issued research reports about the stock. Wall Street Zen cut shares of Trupanion from a "buy" rating to a "hold" rating in a research report on Saturday, December 6th. Zacks Research lowered shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research report on Friday, February 13th. Piper Sandler decreased their price objective on Trupanion from $60.00 to $45.00 and set an "overweight" rating on the stock in a report on Friday, February 13th. Weiss Ratings lowered Trupanion from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Wednesday, March 4th. Finally, Cantor Fitzgerald dropped their target price on Trupanion from $50.00 to $42.00 and set a "neutral" rating for the company in a report on Wednesday, January 14th. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $44.50.

Trupanion Price Performance

TRUP traded down $0.30 during midday trading on Tuesday, hitting $25.49. The stock had a trading volume of 79,785 shares, compared to its average volume of 465,530. The company has a market cap of $1.11 billion, a P/E ratio of 56.65 and a beta of 1.62. The business has a fifty day moving average of $28.70 and a 200 day moving average of $35.59. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.69 and a current ratio of 1.69. Trupanion has a 1 year low of $24.32 and a 1 year high of $57.88.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.01). The business had revenue of $376.85 million for the quarter, compared to analysts' expectations of $375.89 million. Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The company's revenue was up 11.7% compared to the same quarter last year. During the same period last year, the business posted $0.04 earnings per share. As a group, equities analysts forecast that Trupanion will post 0.13 earnings per share for the current fiscal year.

Insider Buying and Selling at Trupanion

In other news, CFO Fawwad Qureshi sold 2,837 shares of the company's stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $26.46, for a total transaction of $75,067.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO John R. Gallagher sold 5,283 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $26.52, for a total transaction of $140,105.16. Following the sale, the chief operating officer owned 32,387 shares of the company's stock, valued at approximately $858,903.24. This represents a 14.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 21,072 shares of company stock valued at $569,363 in the last quarter. Company insiders own 5.42% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Federated Hermes Inc. bought a new stake in shares of Trupanion in the 3rd quarter worth approximately $33,000. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Trupanion during the third quarter valued at approximately $39,000. Kemnay Advisory Services Inc. purchased a new stake in Trupanion in the fourth quarter worth $64,000. Kelleher Financial Advisors purchased a new stake in Trupanion in the third quarter worth $74,000. Finally, PNC Financial Services Group Inc. boosted its holdings in Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider's stock valued at $116,000 after acquiring an additional 478 shares in the last quarter.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.